Literature DB >> 15907252

Opioids for neuropathic pain.

Nathaniel Katz1, Christine Benoit.   

Abstract

Whether opioids are effective for neuropathic pain has been a matter of controversy for decades. Within limits, it is clear that opioids in general are effective for neuropathic pain. Furthermore, there is no evidence that opioids are any less effective for neuropathic pain than for non-neuropathic pain, no evidence that opioids are less effective for neuropathic pain than are other medications, and no evidence that one opioid is any more effective than another for neuropathic pain. It remains uncertain whether opioids are effective for central pain, although they may have a role. Although some patients appear to enjoy long-term benefits, most studies have been short-term. Opioids have an important role in the treatment of neuropathic pain; however, skillful opioid use balances the benefits with management of side effects and prevention and treatment of abuse and addiction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907252     DOI: 10.1007/s11916-005-0056-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  53 in total

1.  MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients.

Authors:  N P Katz
Journal:  J Pain Symptom Manage       Date:  2000-01       Impact factor: 3.612

2.  The effect of opioids on phantom limb pain and cortical reorganization.

Authors:  E Huse; W Larbig; H Flor; N Birbaumer
Journal:  Pain       Date:  2001-02-01       Impact factor: 6.961

3.  Can opiates relieve neuropathic pain?

Authors:  Howard L Fields
Journal:  Pain       Date:  1988-12       Impact factor: 6.961

4.  Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial.

Authors:  Jacques R Caldwell; Ronald J Rapoport; Jeffrey C Davis; Howard L Offenberg; Howard W Marker; Sanford H Roth; William Yuan; Lise Eliot; Najib Babul; Pia Mikkelsen Lynch
Journal:  J Pain Symptom Manage       Date:  2002-04       Impact factor: 3.612

Review 5.  Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

Authors:  Søren H Sindrup; Troels S Jensen
Journal:  Pain       Date:  1999-12       Impact factor: 6.961

6.  Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy.

Authors:  C Peter N Watson; Dwight Moulin; Judith Watt-Watson; Allan Gordon; John Eisenhoffer
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

7.  Sex hormone suppression by intrathecal opioids: a prospective study.

Authors:  Lindy J Roberts; Phillip M Finch; Peter T Pullan; Chotoo I Bhagat; Leanne M Price
Journal:  Clin J Pain       Date:  2002 May-Jun       Impact factor: 3.442

8.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain.

Authors:  S Arnér; B A Meyerson
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

9.  Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.

Authors:  C P Watson; N Babul
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

10.  Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy.

Authors:  Y Harati; C Gooch; M Swenson; S Edelman; D Greene; P Raskin; P Donofrio; D Cornblath; R Sachdeo; C O Siu; M Kamin
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  7 in total

1.  A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.

Authors:  T G Tzellos; G Papazisis; K A Toulis; Ch Sardeli; D Kouvelas
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

Review 2.  [Current therapy of neuropathic pain].

Authors:  M Schäfers; T R Tölle
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

Review 3.  Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature.

Authors:  Thrasivoulos G Tzellos; Georgios Papazisis; Ekaterini Amaniti; Dimitrios Kouvelas
Journal:  Eur J Clin Pharmacol       Date:  2008-07-08       Impact factor: 2.953

4.  The influence of μ-opioid and noradrenaline reuptake inhibition in the modulation of pain responsive neurones in the central amygdala by tapentadol in rats with neuropathy.

Authors:  Leonor Gonçalves; Lauren V Friend; Anthony H Dickenson
Journal:  Eur J Pharmacol       Date:  2015-01-06       Impact factor: 4.432

Review 5.  Imaging central pain syndromes.

Authors:  Dieuwke S Veldhuijzen; Joel D Greenspan; Jong H Kim; Robert C Coghill; Rolf-Detlef Treede; Shinji Ohara; Frederick A Lenz
Journal:  Curr Pain Headache Rep       Date:  2007-06

6.  Going beyond efficacy: strategies for cancer pain management.

Authors:  J Myers; N Shetty
Journal:  Curr Oncol       Date:  2008-01       Impact factor: 3.677

7.  Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials.

Authors:  Diana S Meske; Oluwadolapo D Lawal; Harrison Elder; Valerie Langberg; Florence Paillard; Nathaniel Katz
Journal:  J Pain Res       Date:  2018-05-03       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.